The study to evaluate the efficacy and safety of using Platelet-rich plasma in treatment of Tear Trough Deformity
Phase 4
Recruiting
- Conditions
- HealthyPlatelet-rich plasma, Tear Trough Deformity
- Registration Number
- TCTR20230518002
- Lead Sponsor
- ASTRACO MEDICAL NETWORKS LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1. Aged 30-60 years
2. Tear Trough Class I-II by Hirmard's Classification
Exclusion Criteria
1. Pregnancy or Lactation subjects
2. Subjects with coagulopathy or platelet dysfunction or anemia or cancer or immunocompromised host
3. Current smoking or heavy alcohol drinking subjects
4. Subjects with dermatitis, skin infection at eye
5. Subjects with history of anesthesia allergy
6. Subjects with history of taking contraceptive pills or NSAIDs
7. Subjects who treated with energy-based deviced, laser or botox within 6 month before joining the research
8. Subjects who had history of keloid
9. Subjects who had history of phychiatric disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method